FapsCommunity
Tom Nash from patreon
Tom Nash patreon

Undervalued Stock After Earnings

🕑 Added 2021-02-11 23:54:52 +0000 UTC

Comments

Anton Pleshakov

«П...дец ох...шая компания» - буду брать 😁

Michael Fischer

Apple and Samsung are rumored to be releasing their next gen watches with the CGM feature built in. How do you see that competition affecting the valuation of this company?

Tom Deschenes

Perfect timing, bought in the morning at the bottom. 387

k c

Tom this is great work bringing DexCom to our attention. Would be really amazing if you could also look at rising star $SENS and compare/contrast them

Generico Fakero

Not yet

Mike Lin

https://pubmed.ncbi.nlm.nih.gov/32453604/ @Toolfriend, please share insight how Senseonics is truly disruptive? We can all benefit from it. There are other clinical comparison in addition to this one pasted above and these outcome differences are not a drastic step-changer where the market will just flip from the incumbent to this one. And from my past interaction with Dexcom, it’s a giant in this segment with strong commercial presence and good reputation physicians. Not suggesting Senseonics can’t compete just that I can’t find anything THAT unique about them thus far.

Toolfriend

Hello Tom please check this bevor you make the astonishing video This technology is disruptive Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe.

Tom Deschenes

Will the Real Larry, please stand up!

Aryn Nakaoka

I use TD Ameritrade. After hours and premarket are about 2-3 hours extra....

Lyubomir

On which platform can you trade after hours? I am using Trading 212 and I am not allowed to trade after or pre-market. Or maybe I am doing something wrong?

Daniel Johnson

I’ve been using Dexcom for years. The G6 is why it’s up right now because of integration with Tandem pumps and it’s the only CGM FDA approved for testing and decision making, also the only one approved by Medicare

Daniel Johnson

I had Dexcom in stock in the past and I’m also a user (for many years) of their diabetic continuous glucose monitor. I believe most of the upside is gone on this one, $400 is the max. Sorry Tom for not agreeing but I do not think this is a good one for gains in near future. At the nearly $400 price bow, it’s a five year long or better. They look good because of something that happened in the last year or so that will likely not see another repeat to boost vakue

leonardo

I wonder that too

Andrew Knight

owned this since it was in the $100s

Andrew Dykes

$SENS is coming for them!! Please take a look at them Tom!

Michael Fischer

In at 393.74. Thanks Tom!

yazan

This company is almost 100% owned institutional, can this be worrying if these institutes decided to shift their money to another company?

Jeremy Bass

This is excellent financial advice! Thank you Larry!😬

Aryn Nakaoka

What about 9/2021 calls @ $500 for $23.30 - is that a good way to play this? Or how about 1/21/2022 ($500 Strike) $35.50? 1/20/2023 $500 Strike is $69.30 ....

Anson Cheung

How about the upcoming competitor SENS?

Aryn Nakaoka

Afterhours is presenting a good buying opportunity.

Ahmed Hussain

Bro what do you think about hyln

Gabriel Mishler

SENS

k c

Big fan of this company. Their product the G6 is pretty incredible. Also some news from today: https://www.investors.com/news/technology/dexcom-stock-dexcom-earnings-q4-2020/

Swizz Mike

Do you have already a position on it?


More Creators